Company: TACOW
Filing Date: 2025-04-18
Form Type: S-1/A
Source: 0001829126-25-002771
Chunk: 334

Company: Berto Acquisition Corp.
Filing Date: 2025-04-18
Form: S-1/A
Chunk 334
---
ation of a Business Combination, less funds sourced by Initial Shareholders, or any cash remaining in the trust pursuant
to structured agreements such as forward purchase agreements, non-redemption agreements, any agreements or arrangements alike,
or any other incentivization provided to the shareholders to not to redeem.

The Underwriter Warrants will be identical to
the Public Warrants and Private Placement Warrants.

<div align='center'>F-15

BERTO ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2024</div>

Consulting Agreement

On November 11, 2024, the Company entered
into a consulting agreement with Meteora, pursuant to which Meteora provided consulting, advisory and related services to Company
with respect to general special purpose acquisition company structuring and capital markets matters.

The Company agreed to sell 300,000 Founder Shares
to Meteora for an aggregate purchase price of $1,043. The Company estimated the fair value of such shares of $150,000 based on Monte Carlo
simulation model and recognized stock-based compensation expenses for such services within Deferred Offering Costs in the accompanying
balance sheet.

Note 7 — Shareholders’ Deficit

Preference Shares

The Company is authorized to issue 5,000,000
preferred shares with a par value of $0.001 per share with such designations, voting and other rights and preferences as may be
determined from time to time by the Company’s board of directors. As of December 31, 2024, there were no preferred shares
issued or outstanding.

Ordinary Shares

The Company is authorized to issue 550,000,000
ordinary shares with a par value of $0.001 per share. As of December 31, 2024, there was an aggregate of 7,187,500 shares
issued and outstanding. Of these, up to an aggregate of 937,500 shares are subject to forfeiture depending on the extent to which
the over-allotment option is not exercised by the underwriters so that the Founder Shares will represent 20% of the Company’s
issued and outstanding shares after the Proposed Public Offering.

Ordinary shareholders of record are entitled
to one vote for each share held on all matters to be voted on by shareholders. Unless specified in our articles, or as required
by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of our ordinary
shares that are represented in